Assessing mRNA Integrity using Capillary Electrophoresis: Insights into Scientific Parameters

Bibliographic Details
Main Author: Souza, Raysa Silva de
Publication Date: 2024
Other Authors: Correia, Ingrid Silva, Azevedo, Rafaele Loureiro de, Costa, Mayla Abrahim, Silva Junior, Haroldo Cid da, Guterres, Alexandro, Neves, Patrícia Cristina da Costa, Viveiros, Diana Dalzy, Ano Bom, Ana Paula Dinis
Format: Conference object
Language: eng
Source: Repositório Institucional da FIOCRUZ (ARCA)
DOI: 10.35259/isi.biomang.2024_63902
Download full: https://arca.fiocruz.br/handle/icict/63902
Summary: Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.
id CRUZ_e6439145baefff0371c900fd868a8eb8
oai_identifier_str oai:arca.fiocruz.br:icict/63902
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Souza, Raysa Silva deCorreia, Ingrid SilvaAzevedo, Rafaele Loureiro deCosta, Mayla AbrahimSilva Junior, Haroldo Cid daGuterres, AlexandroNeves, Patrícia Cristina da CostaViveiros, Diana DalzyAno Bom, Ana Paula Dinis2024-05-06T16:51:40Z2024-05-06T16:51:40Z2024SOUZA, Rayssa Silva de Souza. Assessing mRNA Integrity using Capillary Electrophoresis: Insights into Scientific Parameters. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 8., 2024. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2024. p. 26https://arca.fiocruz.br/handle/icict/6390210.35259/isi.biomang.2024_63902engFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos)Vacinas de mRNAIntegridade do mRNAmRNA-based vaccinesmRNA integrityStandardized parametersVacinas de mRNARNA Mensageiro03 Saúde e Bem-EstarAssessing mRNA Integrity using Capillary Electrophoresis: Insights into Scientific Parametersinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectFundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.Introduction: The rise of mRNA-based vaccines through via in vitro transcription (IVT) has seen rapid development and widespread acceptance due to their potential in the combating of diseases. Ensuring mRNA integrity in these therapies is critical for efficacy and safety. Evaluating mRNA purity using capillary gel electrophoresis is crucial, involving a meticulous analysis of mRNA degradation and abortive mRNA species, directly impacting vaccine effectiveness and safety. Objectives: Due to insufficient parameters in scientific literature for mRNA integrity analyses via IVT in biopharmaceutical development, our study aimed to explore two critical parameters. We investigated the impact of user-controlled variables: adjusting the minimum RFU (Relative Fluorescence Units) threshold for signal processing and selecting the 'smear analysis' function (specific areas) in capillary electrophoresis. Methodology: We evaluated three IVT mRNAs, each about 4,000 nucleotides long, using capillary electrophoresis on the Agilent 5200 Fragment Analyzer with DNF-471 RNA kit, following the manufacturer's guidelines. Sample preparation and analysis assessed IVT mRNA size and integrity. Results: Our analysis involved three IVT mRNA samples, with 'smear analysis' set at 10% on both sides. We tested minimum RFU values of 5, 10, 20, and 100. At 5 RFU, peak percentages were 91.1%, 88.3%, and 67.1%. With 10 RFU, the values were 91.9%, 88.7%, and 68.8%, while at 20 RFU they increased to 93.7%, 89.6%, and 71.9%. Employing 100 RFU yielded 100%, 96.8%, and 92.9%. Higher RFU and broader 'smear analysis' windows led to less stringent quality control for IVT mRNA samples. Conclusion: The gap in standardized parameters in the current literature highlights the potential for diverse estimations of mRNA integrity in IVT samples. Addressing this is crucial for the rigorous analysis of IVT-based immunotherapeutic products. Maintaining a standardized minimum RFU value enhances the reliability and comparability of the results. Selecting a fixed peak window percentage, like 10-20% on both sides of RNA size, enables a comprehensive evaluation of mRNA integrity. Implementing these factors bolsters scientific integrity, instilling confidence in findings' accuracy and reproducibility.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://arca.fiocruz.br/bitstreams/c91e0256-f1d8-40cd-813c-dc96b76fdcf3/download5a560609d32a3863062d77ff32785d58MD51falseAnonymousREADORIGINALAnais8thISI2024(FINAL)_26.pdfAnais8thISI2024(FINAL)_26.pdfapplication/pdf193253https://arca.fiocruz.br/bitstreams/924473b3-1aa1-4565-b62e-252637a868d8/download5c59cdf16c48bbfba9d4f620a637e05bMD52trueAnonymousREADPôster ISI_2024.pdfPôster ISI_2024.pdfapplication/pdf3213132https://arca.fiocruz.br/bitstreams/029d066a-abf3-4bd5-a740-4ae632790c2e/downloadc05a305923cc12e2ae6306a0f7e6011fMD53falseAnonymousREADTEXTAnais8thISI2024(FINAL)_26.pdf.txtAnais8thISI2024(FINAL)_26.pdf.txtExtracted texttext/plain2792https://arca.fiocruz.br/bitstreams/0377940d-f6bd-4181-ac46-de865703e1d1/downloadb7fb835d21603c4d672e7a4f2a3fcc12MD58falseAnonymousREADPôster ISI_2024.pdf.txtPôster ISI_2024.pdf.txtExtracted texttext/plain2757https://arca.fiocruz.br/bitstreams/3cd8e5c4-c603-4ea5-81c0-cf49c18e243a/downloadac9a67d82b89a524c9c8c28bcc63a7deMD510falseAnonymousREADTHUMBNAILAnais8thISI2024(FINAL)_26.pdf.jpgAnais8thISI2024(FINAL)_26.pdf.jpgGenerated Thumbnailimage/jpeg4444https://arca.fiocruz.br/bitstreams/dc249793-8dee-46ce-85e1-126068ceb417/download84fd8b01483e9d42dd9e63c8fb8542f4MD59falseAnonymousREADPôster ISI_2024.pdf.jpgPôster ISI_2024.pdf.jpgGenerated Thumbnailimage/jpeg5764https://arca.fiocruz.br/bitstreams/229edb65-2349-4ba3-b03b-57f40ccc0ed7/download81457716dabbe4d92aca7d163faea12dMD511falseAnonymousREADicict/639022025-07-29 23:27:33.533open.accessoai:arca.fiocruz.br:icict/63902https://arca.fiocruz.brRepositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352025-07-30T02:27:33Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)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
dc.title.none.fl_str_mv Assessing mRNA Integrity using Capillary Electrophoresis: Insights into Scientific Parameters
title Assessing mRNA Integrity using Capillary Electrophoresis: Insights into Scientific Parameters
spellingShingle Assessing mRNA Integrity using Capillary Electrophoresis: Insights into Scientific Parameters
Souza, Raysa Silva de
Vacinas de mRNA
Integridade do mRNA
mRNA-based vaccines
mRNA integrity
Standardized parameters
Vacinas de mRNA
RNA Mensageiro
03 Saúde e Bem-Estar
title_short Assessing mRNA Integrity using Capillary Electrophoresis: Insights into Scientific Parameters
title_full Assessing mRNA Integrity using Capillary Electrophoresis: Insights into Scientific Parameters
title_fullStr Assessing mRNA Integrity using Capillary Electrophoresis: Insights into Scientific Parameters
title_full_unstemmed Assessing mRNA Integrity using Capillary Electrophoresis: Insights into Scientific Parameters
title_sort Assessing mRNA Integrity using Capillary Electrophoresis: Insights into Scientific Parameters
author Souza, Raysa Silva de
author_facet Souza, Raysa Silva de
Correia, Ingrid Silva
Azevedo, Rafaele Loureiro de
Costa, Mayla Abrahim
Silva Junior, Haroldo Cid da
Guterres, Alexandro
Neves, Patrícia Cristina da Costa
Viveiros, Diana Dalzy
Ano Bom, Ana Paula Dinis
author_role author
author2 Correia, Ingrid Silva
Azevedo, Rafaele Loureiro de
Costa, Mayla Abrahim
Silva Junior, Haroldo Cid da
Guterres, Alexandro
Neves, Patrícia Cristina da Costa
Viveiros, Diana Dalzy
Ano Bom, Ana Paula Dinis
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Souza, Raysa Silva de
Correia, Ingrid Silva
Azevedo, Rafaele Loureiro de
Costa, Mayla Abrahim
Silva Junior, Haroldo Cid da
Guterres, Alexandro
Neves, Patrícia Cristina da Costa
Viveiros, Diana Dalzy
Ano Bom, Ana Paula Dinis
dc.subject.other.none.fl_str_mv Vacinas de mRNA
Integridade do mRNA
topic Vacinas de mRNA
Integridade do mRNA
mRNA-based vaccines
mRNA integrity
Standardized parameters
Vacinas de mRNA
RNA Mensageiro
03 Saúde e Bem-Estar
dc.subject.en.none.fl_str_mv mRNA-based vaccines
mRNA integrity
Standardized parameters
dc.subject.decs.none.fl_str_mv Vacinas de mRNA
RNA Mensageiro
dc.subject.ods.none.fl_str_mv 03 Saúde e Bem-Estar
description Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos). Rio de Janeiro, RJ, Brasil.
publishDate 2024
dc.date.accessioned.fl_str_mv 2024-05-06T16:51:40Z
dc.date.available.fl_str_mv 2024-05-06T16:51:40Z
dc.date.issued.fl_str_mv 2024
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/conferenceObject
format conferenceObject
status_str publishedVersion
dc.identifier.citation.fl_str_mv SOUZA, Rayssa Silva de Souza. Assessing mRNA Integrity using Capillary Electrophoresis: Insights into Scientific Parameters. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 8., 2024. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2024. p. 26
dc.identifier.uri.fl_str_mv https://arca.fiocruz.br/handle/icict/63902
dc.identifier.doi.none.fl_str_mv 10.35259/isi.biomang.2024_63902
identifier_str_mv SOUZA, Rayssa Silva de Souza. Assessing mRNA Integrity using Capillary Electrophoresis: Insights into Scientific Parameters. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 8., 2024. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2024. p. 26
10.35259/isi.biomang.2024_63902
url https://arca.fiocruz.br/handle/icict/63902
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos)
publisher.none.fl_str_mv Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos)
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://arca.fiocruz.br/bitstreams/c91e0256-f1d8-40cd-813c-dc96b76fdcf3/download
https://arca.fiocruz.br/bitstreams/924473b3-1aa1-4565-b62e-252637a868d8/download
https://arca.fiocruz.br/bitstreams/029d066a-abf3-4bd5-a740-4ae632790c2e/download
https://arca.fiocruz.br/bitstreams/0377940d-f6bd-4181-ac46-de865703e1d1/download
https://arca.fiocruz.br/bitstreams/3cd8e5c4-c603-4ea5-81c0-cf49c18e243a/download
https://arca.fiocruz.br/bitstreams/dc249793-8dee-46ce-85e1-126068ceb417/download
https://arca.fiocruz.br/bitstreams/229edb65-2349-4ba3-b03b-57f40ccc0ed7/download
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
5c59cdf16c48bbfba9d4f620a637e05b
c05a305923cc12e2ae6306a0f7e6011f
b7fb835d21603c4d672e7a4f2a3fcc12
ac9a67d82b89a524c9c8c28bcc63a7de
84fd8b01483e9d42dd9e63c8fb8542f4
81457716dabbe4d92aca7d163faea12d
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1839716214483451904